指南与共识腹部泌尿生殖MR

对高危患者钆塞酸增强MRI诊断肝细胞癌现行指南的回顾性分析

Retrospective analysis of current guidelines for hepatocellular carcinoma diagnosis on gadoxetic acid-enhanced MRI in at-risk patients.
指南 / 共识 · Eur Radiol · 2021-01-03

该研究回顾性纳入3个中心386例高危患者的447个1-3 cm结节,比较5部指南在钆塞酸增强MRI上的诊断效能。KLCA-NCC与APASL指南敏感度(82.3-90.6%)和准确率(83.9-88.6%)最高,OPTN/UNOS指南特异度最高(94.9-97.1%)。

要点

  • KLCA-NCC与APASL指南在钆塞酸增强MRI上诊断HCC的敏感度和准确率最高。
  • OPTN/UNOS指南特异度最高,仅与APASL指南差异有统计学意义。
  • 观察者间对影像特征的一致性为中等至几乎完全一致(κ=0.73-0.87)。

核心结论

  • 在钆塞酸增强MRI诊断HCC时,KLCA-NCC和APASL指南的敏感度和准确率最高,OPTN/UNOS指南的特异度最高。
  • 认识各指南的相对优缺点有助于根据临床情境调整诊断标准。

研究设计与样本

  • 回顾性研究,从3个中心纳入386例高危患者共447个1-3 cm结节(310个HCC、20个混合型肝细胞-胆管细胞癌、2个胆管细胞癌、115个良性病变)。
  • 患者在接受US/CT监测后行钆塞酸增强MRI,由3名放射科医师独立评估与各指南诊断标准相关的肝脏结节影像特征。
  • 以logistic回归联合广义估计方程比较各指南的病灶水平敏感度、特异度和准确率,用Fless κ统计量评估观察者间一致性。

诊断标准与关键数值

  • KLCA-NCC和APASL指南敏感度为82.3-90.6%(p<.001),准确率为83.9-88.6%,在5部指南中最高。
  • OPTN/UNOS指南特异度最高(94.9-97.1%),其后依次为AASLD/LI-RADS、EASL、KLCA-NCC和APASL指南,仅与APASL指南差异有统计学意义。
  • 更新版AASLD/LI-RADS与EASL指南之间、KLCA-NCC与APASL指南之间的诊断效能相当(p>.05)。
  • 观察者间对影像特征的一致性为中等至几乎完全一致(κ=0.73-0.87)。

临床应用与阅片要点

  • 在乙型肝炎流行区使用钆塞酸增强MRI诊断HCC时,可参考KLCA-NCC和APASL指南对敏感度和准确率的优势。
  • 当需要更高特异度时,可参考OPTN/UNOS指南的特异度表现。
  • 作者认为,拓宽动脉期明显强化、廓清的定义以及可适用诊断标准的病灶大小,可能改善乙型肝炎流行区HCC的诊断效能。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate and compare the diagnostic performance of the updated HCC guidelines using gadoxetic acid-enhanced MRI.

METHODS: In this study, patients at risk of HCC who underwent gadoxetic acid-enhanced MRI following US/CT surveillance were retrospectively recruited from 3 centers. Three radiologists independently evaluated hepatic nodule imaging features relevant to the diagnostic criteria outlined in each guideline. Per-lesion sensitivity, specificity, and accuracy were compared between guidelines using logistic regression with a generalized estimating equation. Inter-observer agreements on imaging features were determined using Fless κ statistics.

RESULTS: Altogether, 447 nodules (310 HCCs, 20 combined hepatocellular-cholangiocarcinomas, 2 cholangiocarcinomas, and 115 benign entities) measuring 1-3 cm from 386 patients were assessed. The KLCA-NCC and APASL guidelines showed the highest sensitivity (82.3-90.6%, p < .001) and accuracy (83.9-88.6%) among the five guidelines. The OPTN/UNOS guideline showed the highest specificity (94.9-97.1%), followed by the AASLD/LI-RADS, EASL, KLCA-NCC, and APASL guidelines, with significant difference only with the APASL guideline. The diagnostic performance of the updated AASLD/LI-RADS and EASL guidelines and of the KLCA-NCC and APASL guidelines was comparable (p > .05). Inter-observer agreement was substantial to almost perfect (κ = 0.73-0.87).

CONCLUSIONS: For the diagnosis of HCC using gadoxetic acid-enhanced MRI, the KLCA-NCC and APASL guidelines showed the highest sensitivity and accuracy. The OPTN/UNOS guideline showed the highest specificity. Acknowledging their relative strengths and weaknesses could help adapt the diagnostic criteria according to the clinical context.

KEY POINTS: • APASL and KLCA-NCC provided significantly the highest sensitivity and accuracy, followed by AASLD/LI-RADS and EASL in an endemic area for hepatitis B. • OPTN/UNOS showed the highest specificity, followed by AASLD/LI-RADS, EASL, KLCA-NCC, and APASL guidelines, with significant difference only with APASL. • Broadened definition of arterial hyperenhancement, washout, and the size of the lesion eligible to apply diagnostic criteria may improve the diagnostic performance for HCC in an endemic area for hepatitis B.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Park SH, Shim YS, Kim B, et al. Retrospective analysis of current guidelines for hepatocellular carcinoma diagnosis on gadoxetic acid-enhanced MRI in at-risk patients. Eur Radiol. 2021. PMID: 33389037. doi:10.1007/s00330-020-07577-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。